These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 21376033)

  • 21. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
    Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
    Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms by which the antitumor compound di-n-butyl-di-(4-chlorobenzohydroxamato)tin(IV) induces apoptosis and the mitochondrial-mediated signaling pathway in human cancer SGC-7901 cells.
    Li Y; Liu J; Li Q
    Mol Carcinog; 2010 Jun; 49(6):566-81. PubMed ID: 20336762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
    Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel oxiranylchromenone derivative, MHY336, induces apoptosis and cell cycle arrest via a p53- and p21-dependent pathway in HCT116 human colon cancer cells.
    Lee SH; Kang YJ; Kim DH; Sung B; Kang JA; Chun P; Yoon JH; Moon HR; Kim HS; Chung HY; Kim ND
    Int J Oncol; 2014 Mar; 44(3):943-9. PubMed ID: 24365999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
    Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
    Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells.
    Morrissey C; O'Neill A; Spengler B; Christoffel V; Fitzpatrick JM; Watson RW
    Prostate; 2005 May; 63(2):131-42. PubMed ID: 15486995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4β-amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer.
    Reddy VG; Bonam SR; Reddy TS; Akunuri R; Naidu VGM; Nayak VL; Bhargava SK; Kumar HMS; Srihari P; Kamal A
    Eur J Med Chem; 2018 Jan; 144():595-611. PubMed ID: 29289884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
    Lu X; Hsieh TC; Wu JM
    Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.
    Brel V; Annereau JP; Vispé S; Kruczynski A; Bailly C; Guilbaud N
    Biochem Pharmacol; 2011 Dec; 82(12):1843-52. PubMed ID: 21924246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90.
    Lee MG; Liu YC; Lee YL; El-Shazly M; Lai KH; Shih SP; Ke SC; Hong MC; Du YC; Yang JC; Sung PJ; Wen ZH; Lu MC
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29890785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate.
    Singh RP; Agrawal P; Yim D; Agarwal C; Agarwal R
    Carcinogenesis; 2005 Apr; 26(4):845-54. PubMed ID: 15637089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of the antitumor effect of 11-keto-β-boswellic acid by its 3-α-hexanoyloxy derivative.
    Chashoo G; Singh SK; Mondhe DM; Sharma PR; Andotra SS; Shah BA; Taneja SC; Saxena AK
    Eur J Pharmacol; 2011 Oct; 668(3):390-400. PubMed ID: 21821018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
    Gupta S; Afaq F; Mukhtar H
    Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S; Srivastava RK
    Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B1, a novel topoisomerase II inhibitor, induces apoptosis and cell cycle G1 arrest in lung adenocarcinoma A549 cells.
    Cheng MH; Yang YC; Wong YH; Chen TR; Lee CY; Yang CC; Chen SH; Yang IN; Yang YS; Huang HS; Yang CY; Huang MS; Chiu HF
    Anticancer Drugs; 2012 Feb; 23(2):191-9. PubMed ID: 22008852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
    Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
    Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J; Chervin AS; Nie A; Ducoff HS; Huang Z
    Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.
    Roy S; Packman K; Jeffrey R; Tenniswood M
    Cell Death Differ; 2005 May; 12(5):482-91. PubMed ID: 15746940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.